Cognitive Behavioral Therapy Cost-Effective in Depressed Teens

Share this content:
Cognitive Behavioral Therapy Cost-Effective in Depressed Teens
Cognitive Behavioral Therapy Cost-Effective in Depressed Teens

FRIDAY, Jan. 19, 2018 (HealthDay News) -- For adolescents with depression who declined or quickly stopped using antidepressants, a brief cognitive behavioral therapy (CBT) program is cost-effective, according to a study published online Jan. 19 in Pediatrics.

John F. Dickerson, Ph.D., from the Kaiser Permanente Center for Health Research in Portland, Ore., and colleagues randomized 212 youth with depression to treatment as usual (TAU) or TAU plus brief individual CBT. Depression-free days (DFD) and estimated quality-adjusted life-years (QALYs) were assessed as clinical outcomes. Over 12- and 24-month follow-up periods, incremental cost-effectiveness ratios (ICERs) comparing CBT with TAU were calculated.

The researchers found that over 12 months, youth randomized to CBT versus TAU had 26.8 more DFDs (P = 0.044) and 0.067 more QALYs (P = 0.044) on average. By the end of the 24-month follow-up period, the total costs were $4,976 less (P = 0.025) among youth randomized to CBT. Per DFD, the total costs were −$51 and −$115 at 12 and 24 months, respectively (ICER, −$51 [95 percent confidence interval, −$394 to $9] and −$115 [95 percent confidence interval, −$1,090 to −$6], respectively). Per QALY, the total costs were −$20,282 and −$45,792 at 12 and 24 months, respectively (ICER, −$20,282 [95 percent confidence interval, −$156,741 to $3,617] and −$45,792 [95 percent confidence interval, −$440,991 to −$2,731], respectively).

"Brief primary care CBT among youth declining antidepressant therapy is cost-effective by widely accepted standards in depression treatment," the authors write. "CBT becomes dominant over TAU over time, as revealed by a statistically significant cost offset at the end of the two-year follow-up."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Congo Ebola Outbreak Now Second Worst in History

Congo Ebola Outbreak Now Second Worst in History

The worst Ebola outbreak occurred in West Africa in 2014 to 2016

FDA to Resume Inspections of Riskier Foods

FDA to Resume Inspections of Riskier Foods

Agency is bringing back about 150 unpaid employees for the inspections of riskier foods

Breakdown of Blood-Brain Barrier May Drive Dementia

Breakdown of Blood-Brain Barrier May Drive Dementia

Leaky brain capillaries tied to cognitive dysfunction, independent of protein markers for dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »